STREPTOLYSIN PRODUCTION IN CARBOHYDRATE MEDIA

Diversity of β-hemolysins produced by the human opportunistic streptococci

The genus Streptococcus infects a broad range of hosts, including humans. Some species, such as S. pyogenes, S. agalactiae, S. pneumoniae, and S. mutans, are recognized as the major human pathogens, and their pathogenicity toward humans has been investigated. However, many of other streptococcal species have been recognized as opportunistic pathogens in humans, and their clinical importance has been underestimated. In our previous study, the Anginosus group streptococci (AGS) and Mitis group streptococci (MGS) showed clear β-hemolysis on blood agar, and the factors responsible for the hemolysis were homologs of two types of β-hemolysins, cholesterol-dependent cytolysin (CDC) and streptolysin S (SLS). In contrast to the regular β-hemolysins produced by streptococci (typical CDCs and SLSs), genetically, structurally, and functionally atypical β-hemolysins have been observed in AGS and MGS. These atypical β-hemolysins are thought to affect and contribute to the pathogenic potential of opportunistic streptococci mainly inhabiting the human oral cavity. In this review, we introduce the diverse characteristics of β-hemolysin produced by opportunistic streptococci, focusing on the species/strains belonging to AGS and MGS, and discuss their pathogenic potential.

RELATION BETWEEN THE VIRULENCE OF STREPTOCOCCI AND HEMOLYSIN

Strains of streptococci whose virulence has been increased for any one species of animal do not produce greater concentrations of hemolysin than the original strain. Furthermore, there is a tendency for the original culture to grow more rapidly than the more pathogenic form, and to reach the height of hemolysin production at an earlier stage during the growth of the culture. These conclusions can probably be applied only to experiments in which the serum used in the media is from some species not employed for the animal passages.